HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial

MH Komulainen, H Kroger, MT Tuppurainen… - Maturitas, 2008 - Elsevier
OBJECTIVES: We investigated the incidence of new non-vertebral fractures during HRT or
low-dose vitamin (Vit) D3 supplementation in a 5-year prospective trial. METHODS: A total of …

Two cases of placenta accreta managed conservatively

MH Komulainen, MA Väyrynen, ML Kauko… - European Journal of …, 1995 - Elsevier
Placenta accreta is a rare complication of pregnancy. Traditionally treatment has been
operative, commonly total abdominal hysterectomy, in order to prevent serious haemorrhage …

Effects of Postmenopausal Hormone Replacement Therapy With and Without Vitamin D3 on Circulating Levels of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D

AM Heikkinen, MT Parviainen, MT Tuppurainen… - Calcified tissue …, 1998 - Springer
The effects of postmenopausal hormone replacement therapy (HRT) and vitamin D 3 on
vitamin D metabolites (25OHD and 1, 25 (OH) 2 D) were studied in a population-based …

Hormone replacement therapy and risk of falling in early postmenopausal women–a population‐based study

KM Randell, RJ Honkanen… - Clinical …, 2001 - Wiley Online Library
OBJECTIVE The purpose of this study was to examine the effect of hormone (oestrogen)
replacement therapy (HRT) on the risk of falling among early postmenopausal women …

Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?

AM Heikkinen, H Kröger, L Niskanen, MH Komulainen… - Maturitas, 2000 - Elsevier
Objectives: Bone mineral density (BMD) and development of osteoporosis are partly
determined by genetic factors. The associations between one of suggested candidate …

Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?

AM Heikkinen, L Niskanen, M Ryynänen… - … , and vascular biology, 1999 - Am Heart Assoc
Postmenopausal hormone replacement therapy (HRT) has favorable effects on the serum
lipid profile, and it also decreases the risk of cardiovascular diseases. The apolipoprotein E …

Bone loss and wrist fractures after withdrawal of hormone therapy: The 15-year follow-up of the OSTPRE cohort

J Saarelainen, S Hassi, R Honkanen… - Maturitas, 2016 - Elsevier
Context Long-term bone mineral density (BMD) or fracture incidence changes after
withdrawal of postmenopausal hormone therapy (HT) are not well known. Objective To study …

Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women

AM Heikkinen, LK Niskanen, JA Salmi, M Koulu… - Bone, 2004 - Elsevier
Neuropeptide Y (NPY) is a versatile neurotransmitter that has recently been shown to
regulate bone metabolism in animal and in vitro studies. We studied the influence of …

Effects of hormone replacement therapy and vitamin D3 on prevention of bone loss and fractures in early postmenopausal women.

MH Komulainen - 2001 - elibrary.ru
Osteoporosis and subsequent fractures have been recognized as a major heath problem
worldwide. The positive effects of hormone replacement therapy (HRT) on bone density and …

0076: Primary Surgery at University Hospitals Improves Survival of Ovarian Cancer-A Prospective Nationwide Study in Finland

SE Grenman, SJ Kumpulainen… - International …, 2006 - search.proquest.com
Background/Aims: Lymph node status is the most important prognostic factor in cervical
cancer. Sentinel lymph node procedures have been purported to reduce peri-and …